Stephen Morlock, Director at BioPharmX Corp (BPMX), bought 330,000 shares at $0.15 ($50K) on 2017-11-24, disclosed to the SEC on 2017-11-27.
Open-market purchase of $50k BPMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| BPMX | BUY | 2016-01-15 | $18K | — | Filing → |
| BPMX | BUY | 2016-01-12 | $9K | — | Filing → |
| BPMX | BUY | 2016-01-11 | $7K | — | Filing → |